On February 9, the U.S. Food and Drug Administration (FDA) cleared for marketing the ENROUTE Transcarotid Neuroprotection System (ENROUTE TNS) for use during carotid angioplasty and stenting. It’s the first device designed to access the carotid arteries through an incision in the neck, instead of the groin, and uses a blood flow reversal system to capture pieces of the blockage dislodged during the procedure. Read more.
© 2021 HealthCom Media All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder